Memic Innovative Surgery Archives - Medical Design Sourcing

Memic completes first robotic-assisted transvaginal hysterectomy procedures with Hominis

[Image from Memic]Memic Innovative Surgery announced today that the first patient procedures were completed with its Hominis system for robotic-assisted transvaginal hysterectomy.

HCA Florida Kendall Hospital and The Women’s Hospital at Jackson Memorial successfully completed the first U.S. patient procedures using Hominis, the first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms, with shoulder, elbow, and wrist joints that provide high dexterity and unprecedented articulation.

The two hospitals that completed the procedures were among the first three U.S. centers to adopt the platform back in January of this year.

Dr. Ricardo E. Estape, a practicing gynecologic oncologist at HCA Florida Kendall Hospital and director of HCA Healthcare’s Institute for Gynecologic Oncology, said in a news release that Hominis provides significant benefits to both surgeons and patients, allowing the hospital to perform robotic s…

Memic Innovative Surgery’s SPAC deal is off

Memic is the developer of Hominis — the first FDA-approved, robotically assisted surgical device for performing transvaginal hysterectomy. [Image from Memic Innovative Surgery]Memic Innovative Surgery and the SPAC called MedTech Acquisition Corp. are calling off the merger that would have taken Memic public.

The two companies said the decision was mutual — the result of market conditions and associated volatility due to recent world events. Memic is the developer of Hominis — the first FDA-approved, robotically assisted surgical device for performing transvaginal hysterectomy.

When announcing the proposed merger last year, the companies had said the deal would create a combined company with an estimated pro-forma equity value of more than $1 billion.

“While we are disappointed that our proposed business combination with Memic will not be consummated, we believe that Memic’s Hominis system and its innovative technology, as well as Memic’s highly accomplish…

Memic Innovative Surgery partners with VirtaMed to develop robotic surgery VR training

Hominis humanoid-shaped arms inside the virtual reality simulation [Image courtesy of VirtaMed]VirtaMed and Memic Innovative Surgery announced today that they will work together to develop virtual reality simulations for surgeons training on Memic’s Hominis surgical system.

The FDA-authorized Hominis surgical robot features small humanoid-shaped arms that include shoulder, elbow and wrist joints to provide human-level dexterity and 360-degree articulation. The surgical robotics system has an indication for use in single-site, natural orifice laparoscopic-assisted transvaginal benign gynecological procedures including benign hysterectomy.

Get the full story on our sister site Medical Design & Outsourcing.

First U.S. facilities adopt Memic Innovative Surgery’s Hominis robotic surgery platform

Image from Memic Innovative Surgery

Memic Innovative Surgery announced today that three U.S.-based facilities acquired the Hominis robot-assisted surgical system.

HCA Florida Healthcare’s Kendall Regional Medical Center, Advent Health Celebration and The Women’s Hospital at Jackson Memorial all acquired the Hominis surgical system.

Tel Aviv, Israel-based Memic’s Hominis system will now be used at the facilities in single-site, natural orifice laparoscopic-assisted transvaginal benign gynecological procedures including benign hysterectomy, according to a news release. The company touts Hominis as the first and only FDA-authorized surgical robot with miniature humanoid-shaped arms with shoulder, elbow and wrist joints that provide human-level dexterity and 360-degree articulation.

Memic — which confirmed its plans to go public in a SPAC merger in August 2021 — designed the Hominis system to replicate the motions and capabilities of a surg…

MedTech 100 roundup: Hot streak comes to slight halt

After several weeks of high-level performance, the medtech industry saw its first dip in a while over the last seven days.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 13) at 117.92 points, marking a -1.2% dip from the 119.41-point tally a week prior (Aug. 6).

Medtech’s performance continues to reflect an overall rebound from the struggles brought on by the COVID-19 pandemic, too. The industry remains well above the marks set around the height of the pandemic, having registered a 27.7% increase from the pre-pandemic high of 92.32 (set on Feb. 19, 2020). Moreover, it remains well ahead of the mid-pandemic low of 62.13 (March 23, 2020) as well, totaling an 89.8% ascent above that point.

The industry’s performance did not correlate with the overall markets this past week as the S&P 500 Index and Dow Jones Industrial Average fared almost identically, ticking up by 0.7% a…

Memic Innovative Surgery to go public via SPAC merger

Image from Memic Innovative Surgery

Memic Innovative Surgery announced that it entered into a merger agreement with special purpose acquisition company MedTech Acquisition Corp.

Tel Aviv, Israel-based Memic will operate under its current name upon the closing of the transaction, with Dr. Maurice R. Ferré — an independent director of MedTech and current chairman of Memic — will serve as executive chairman of the combined company. The companies expect the business combination to be completed in the fourth quarter of this year, according to a news release.

Listen to Dr. Maurice R. Ferré talk surgical robotics on the DeviceTalks Weekly Podcast.

Rumors of a potential SPAC merger popped up in May regarding Memic, which develops Hominis, the first FDA-approved, robotically assisted surgical device for performing transvaginal hysterectomy. At that time, there was no certainty over the completion of a deal.

“We are pleased…

MedTech 100 roundup: Turnaround for the industry?

A turgid month for the medtech industry might be drifting into the past after the past week indicated a slight turnaround as summer nears.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week at 107.74 points, marking a 1.4% rise from the 106.22-point mark set one week prior.

Having endured its largest slide of 2021 in recent weeks, the index is already demonstrating signs of a rebound after April brought the industry’s all-time best performance.

Despite the setbacks that have plagued the industry over the past month or so, medtech’s performance continues to reflect a rebound from the struggles brought on by the COVID-19 pandemic. Overall, it has registered a 16.7% rise from the pre-pandemic high of 92.32 (set on Feb. 19, 2020), plus a 73.4% increase from the mid-pandemic low of 62.13 (March 23, 2020).

The overall markets were on the opposite end of the spectrum over the p…

Report: Memic may go public through merger with SPAC

Memic’s Hominis robot-assisted surgery platform. [Image from Memic Innovative Surgery]Memic Innovative Surgery is reportedly eyeing a move to go public through a merger with SPAC MedTech Acquisition Corp.

Bloomberg reported that people with knowledge of the matter say that Memic, which develops Hominis, the first FDA-approved robotically-assisted surgical device for performing transvaginal hysterectomy, is in talks over going public with the SPAC, although a MedTech Acquisition Corp. representative declined to comment to the outlet, while Memic didn’t immediately respond to requests for comment.

Additionally, the SPAC could raise additional equity through a PIPE (private investment in public equity), Bloomberg reported, while financial terms of the potential merger were not disclosed and there is the possibility that the talks could fall through without an agreement.

Last month, Memic raised $96 million in a Series D financing ro…

Memic raises $96M to support surgical robot with humanoid-shaped arm

Image from Memic Innovative Surgery

Memic Innovative Surgery announced today that it closed a $96 million Series D financing round.

Tel Aviv, Israel-based Memic develops Hominis, the first FDA-approved robotically-assisted surgical device for performing transvaginal hysterectomy, with indication for performing benign hysterectomy with salpingo-oophorectomy. The FDA approved the Hominis system last month.

Hominis is designed to remove the uterus using minimally invasive surgical instruments inserted through the vagina, as well as a video camera inserted laparoscopically through a small incision on the abdomen. The transvaginal approach requires fewer incisions on the abdomen compared to the traditional laparoscopic hysterectomy.

According to a news release, Memic plans to use funding to support the commercialization of the Hominis platform in the U.S. and potentially elsewhere as marketing and sales efforts in other countries are expected to be expanded.<…

DTW Podcast: Can AI, advanced imaging and robotics “democratize” surgery?

A new generation of digital surgery systems will level the playing field for surgeons giving them artificial intelligence, robotic tools and other assistive technologies.

In three interviews in this week’s DeviceTalks Weekly Podcast, leaders form Asensus, ActivSurgical and Memic explain how their systems will improve surgeon performance, reduce errors, and deliver the “democratization” of surgical robotics.

Guests this week include

Anthony Fernando, CEO of Asensus Surgical (formerly Transenterix), outlines the company’s bid to push its Sehance system as a solution for laparoscopic procedures. Fernando, who took over as CEO in 2019, explains why the company’s stock crashed in 2019 and details the changes that he says has started the company’s turnaround. Senhance offers more responsive surgical tools along with data that will help with surgical training and scheduling.

Todd Usen, CEO of ActivSurgical, left a job he loved at Olympus to lead a compan…